Inflammation in lung carcinogenesis: New targets for lung cancer chemoprevention and treatment
- 4 March 2008
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 66 (3) , 208-217
- https://doi.org/10.1016/j.critrevonc.2008.01.004
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) studyThe Lancet Oncology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Matrix Metalloproteinases Promote Inflammation and Fibrosis in Asbestos-Induced Lung Injury in MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Cigarette Smoke–Induced Egr-1 Upregulates Proinflammatory Cytokines in Pulmonary Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- State of the Art. Chronic Obstructive Pulmonary Disease, Inflammation, and Lung CancerProceedings of the American Thoracic Society, 2006
- A Phase I Trial to Determine the Optimal Biological Dose of Celecoxib when Combined with Erlotinib in Advanced Non–Small Cell Lung CancerClinical Cancer Research, 2006
- Inflammatory cells in the airways in COPDThorax, 2006
- Combined Targeting of the Epidermal Growth Factor Receptor and Cyclooxygenase-2 PathwaysClinical Cancer Research, 2005
- Recapitulation of kidney development paradigms by BMP-7 reverses chronic renal injuryClinical and Experimental Nephrology, 2005
- Prostaglandin E2 Synergistically Enhances Receptor Tyrosine Kinase-dependent Signaling System in Colon Cancer CellsJournal of Biological Chemistry, 2004